Patricia Inacio, PhD, science writer —

The use of an inactivated vaccine against SARS-CoV-2, the virus that causes COVID-19, is not linked to an increased risk of symptom worsening among people with myasthenia gravis (MG), according to a small study from China. “COVID-19 vaccination has no long-term impact on MG relapse,” researchers wrote. However, a…

The risk of developing another autoimmune disease, especially rheumatoid arthritis, increased in people with myasthenia gravis (MG) after surgery to remove a thymoma, or a tumor of the thymus gland, according to a recent Chinese study. Women and younger patients were at particularly higher risk. The study, “…

Over 40% of adults with generalized myasthenia gravis (gMG) in the U.S. who began off-label treatment with intravenous immunoglobulin (IVIG) became frequent users, with six or more courses in the first year, according to real-world data covering 1,225 patients. Use of standard treatments, namely corticosteroids and nonsteroidal immunosuppressives,…

Nearly six months of treatment with telitacicept (RC18), an anti-inflammatory developed by RemeGen, safely lessened disease severity in adults with myasthenia gravis (MG) positive for acetylcholine receptor (AChR) antibodies. That’s according to new data from an ongoing Phase 2 trial in China. “The latest Phase II clinical study…

Cour Pharmaceuticals is launching a Phase 1b/2a proof-of-concept study to evaluate the safety and preliminary effectiveness of its investigational therapy CNP-106, an immune-modifying nanoparticle that’s designed to reprogram the immune system in adults with myasthenia gravis (MG). The announcement follows the U.S. Food and Drug Administration’s (FDA) approval of…

People with myasthenia gravis (MG) who are receiving immunosuppressive therapy are more likely to be hospitalized for a COVID-19 infection, yet the majority of patients are discharged without any complications, a single center study reports. “Immunosuppressive therapy was continued during COVID-19 infection,” and “most of hospitalized patients were discharged…

Long-term immunotherapy may cause anemia in female patients with myasthenia gravis (MG), according to a Japanese study that found that women with this blood condition — one of the potential side effects of immunotherapy — had significantly worse disease severity. Anemia, a condition marked by a low…

Virtis Health announced that it will open two ambulatory centers in Ohio — one in Columbus and the other in Cleveland — for people in need of infusion therapies, including those with myasthenia gravis (MG). Virtis is a division of Soleo Health, a pharmacy specialized in the…

Researchers in Iran reported the first case of myasthenia gravis (MG) following a Sinopharm vaccination against SARS-CoV-2, the virus that causes COVID-19. The report follows evidence of a possible link between COVID-19 vaccination and MG. While the mechanisms remain unclear, “if muscle weakness, ocular and bulbar [neck and facial]…

Researchers in Italy have reported three cases of myasthenia gravis (MG) they say may possibly have been caused by a vaccine against SARS-CoV-2, the virus that causes COVID-19. “Clinicians should be aware of possible new-onset MG after SARS-CoV-2 vaccination, especially with the current recommendation of booster doses,” the team…